Medpace Holdings Inc vs Starbucks Corp — how do they compare? Medpace Holdings Inc trades at $530.22 (market cap $15.08B), while Starbucks Corp trades at $104.45 (market cap $119.45B). The key difference: Starbucks Corp is far larger — about 7.9× Medpace Holdings Inc's market cap, and Starbucks Corp pays a 2.37% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | SBUX | |
|---|---|---|
Market Cap | $15.08B | $119.45B |
Sector | Technology | Consumer Cyclical |
52-Week High | $620.59 | $108.37 |
52-Week Low | $308.88 | $78.46 |
Enterprise Value | $14.55B | $142.14B |
Volume | — | 7,493,833 |
Dividend Yield | — | 2.37% |
Trailing returns across standard periods
Latest headlines on both assets
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.
Read more on SBUX →